{"id":"https://openalex.org/W810408096","doi":"https://doi.org/10.4088/jcp.14m09337","title":"A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder","display_name":"A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder","publication_year":2015,"publication_date":"2015-05-27","ids":{"openalex":"https://openalex.org/W810408096","doi":"https://doi.org/10.4088/jcp.14m09337","mag":"810408096","pmid":"https://pubmed.ncbi.nlm.nih.gov/26035186"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.14m09337","doi":"https://doi.org/10.4088/jcp.14m09337","is_oa":true,"landing_page_url":"https://doi.org/10.4088/jcp.14m09337","pdf_url":"https://www.psychiatrist.com/read-pdf/16743","source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.psychiatrist.com/read-pdf/16743","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112910391","display_name":"Atul R. Mahableshwarkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atul R. Mahableshwarkar","raw_affiliation_strings":["CNS Medicine, Takeda Development Center Americas, Deerfield, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Medicine, Takeda Development Center Americas, Deerfield, Illinois","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024369212","display_name":"Paula L. Jacobsen","orcid":"https://orcid.org/0000-0003-0216-655X","observed_orcids":["https://orcid.org/0000-0003-0216-655X"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Paula L. Jacobsen","raw_affiliation_strings":["6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","Takeda Development Center \u2013 Americas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","institution_ids":[]},{"raw_affiliation_string":"Takeda Development Center \u2013 Americas","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089404250","display_name":"Michael Serenko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michael Serenko","raw_affiliation_strings":["6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","Takeda Development Center \u2013 Americas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","institution_ids":[]},{"raw_affiliation_string":"Takeda Development Center \u2013 Americas","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068791484","display_name":"Yinzhong Chen","orcid":"https://orcid.org/0009-0004-5224-4215","observed_orcids":["https://orcid.org/0009-0004-5224-4215"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yinzhong Chen","raw_affiliation_strings":["6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","Takeda Development Center \u2013 Americas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","institution_ids":[]},{"raw_affiliation_string":"Takeda Development Center \u2013 Americas","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081426855","display_name":"Madhukar H. Trivedi","orcid":"https://orcid.org/0000-0002-2983-1110","observed_orcids":["https://orcid.org/0000-0002-2983-1110"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Madhukar H. Trivedi","raw_affiliation_strings":["6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6363 Forest Park Rd , Ste 13.354 , Dallas , TX 75390-9119","institution_ids":[]},{"raw_affiliation_string":"Psychiatry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5081426855"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.5139,"has_fulltext":true,"cited_by_count":86,"citation_normalized_percentile":{"value":0.98498105,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"76","issue":"05","first_page":"583","last_page":"591"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/serotonin-transporter-inhibition","display_name":"serotonin transporter inhibition","score":0.6890000104904175},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.7480000257492065},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7820000052452087},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.8450000286102295},{"id":"https://openalex.org/keywords/suicidal-ideation","display_name":"suicidal ideation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.4359999895095825},{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.8579999804496765},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.38499999046325684},{"id":"https://openalex.org/keywords/adults-with-depression","display_name":"adults with depression","score":0.5809999704360962},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.4189999997615814},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.3630000054836273},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.328000009059906}],"concepts":[{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.9743409156799316},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7473108172416687},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5848997235298157},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.528694748878479},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5109359622001648},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46212315559387207},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.449725866317749},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4001975357532501},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3825957179069519},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3231308162212372},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.2837967276573181},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078784","descriptor_name":"Vortioxetine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.14m09337","doi":"https://doi.org/10.4088/jcp.14m09337","is_oa":true,"landing_page_url":"https://doi.org/10.4088/jcp.14m09337","pdf_url":"https://www.psychiatrist.com/read-pdf/16743","source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:26035186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26035186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4088/jcp.14m09337","doi":"https://doi.org/10.4088/jcp.14m09337","is_oa":true,"landing_page_url":"https://doi.org/10.4088/jcp.14m09337","pdf_url":"https://www.psychiatrist.com/read-pdf/16743","source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W810408096.pdf","grobid_xml":"https://content.openalex.org/works/W810408096.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1970755410","https://openalex.org/W1985083533","https://openalex.org/W1987514922","https://openalex.org/W1992333267","https://openalex.org/W1993810702","https://openalex.org/W2011606125","https://openalex.org/W2029732660","https://openalex.org/W2036812642","https://openalex.org/W2048026164","https://openalex.org/W2054766240","https://openalex.org/W2058572593","https://openalex.org/W2059274457","https://openalex.org/W2061669920","https://openalex.org/W2064563389","https://openalex.org/W2071735605","https://openalex.org/W2086325363","https://openalex.org/W2131823335","https://openalex.org/W2138959943","https://openalex.org/W2159271064","https://openalex.org/W2160070901","https://openalex.org/W2164182651","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2752826413","https://openalex.org/W845297282","https://openalex.org/W1986102787","https://openalex.org/W2054766240","https://openalex.org/W2001782289","https://openalex.org/W2061669920","https://openalex.org/W2770211753","https://openalex.org/W803311982","https://openalex.org/W2303297560","https://openalex.org/W2985924852"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"8-week,":[2],"randomized,":[3],"double-blind,":[4],"placebo-controlled":[5],"study,":[6,120,272],"conducted":[7],"August":[8],"2010-May":[9],"2012":[10],"in":[11,27,105,173,203,216,220,226,235,289],"the":[12,16,56,93,119,128,140,148,174,221,227,236,260],"United":[13],"States,":[14],"evaluated":[15],"safety":[17],"and":[18,24,53,67,123,134,164,199,232],"efficacy":[19,95,176],"of":[20,36,38,48,55,206,287],"vortioxetine":[21,39,82,161,167,184,188,228,237,273],"10":[22,83,162,185,229],"mg":[23,26,84,87,186,230,239],"15":[25,86,168,189,238],"patients":[28],"with":[29,64,92],"major":[30],"depressive":[31],"disorder":[32],"(MDD).":[33],"The":[34],"mechanism":[35],"action":[37],"is":[40],"thought":[41],"to":[42,45,80,157,160,166,212],"be":[43],"related":[44],"direct":[46],"modulation":[47],"serotonin":[49,57],"(5-HT)":[50],"receptor":[51],"activity":[52],"inhibition":[54],"transporter.":[58],"METHOD:":[59],"Adults":[60],"aged":[61],"18-75":[62],"years":[63],"MDD":[65,290],"(DSM-IV-TR)":[66],"Montgomery-Asberg":[68],"Depression":[69],"Rating":[70,131],"Scale":[71,132],"(MADRS)":[72],"total":[73,242,282],"score":[74,283],"\u2265":[75,204],"26":[76],"were":[77,116,125,154,179,201,244,249],"randomized":[78],"(1:1:1)":[79],"receive":[81],"or":[85,88,187,255,265],"placebo":[89,172,222,279],"once":[90],"daily,":[91],"primary":[94,175],"end":[96,177],"point":[97,178],"being":[98],"change":[99],"from":[100,171,278],"baseline":[101],"at":[102],"week":[103],"8":[104,224,285],"MADRS":[106,281],"analyzed":[107],"by":[108],"mixed":[109],"model":[110],"for":[111,183],"repeated":[112],"measures.":[113],"Adverse":[114],"events":[115,214],"recorded":[117],"during":[118],"suicidal":[121],"ideation":[122],"behavior":[124],"assessed":[126,138],"using":[127,139],"Columbia-Suicide":[129],"Severity":[130],"(C-SSRS),":[133],"sexual":[135],"dysfunction":[136],"was":[137],"Arizona":[141],"Sexual":[142],"Experience":[143],"(ASEX)":[144],"scale.":[145],"RESULTS:":[146],"Of":[147],"1,111":[149],"subjects":[150,153,207,218],"screened,":[151],"469":[152],"randomized:":[155],"160":[156],"placebo,":[158],"157":[159],"mg,":[163],"152":[165],"mg.":[169,190],"Differences":[170],"not":[180,275],"statistically":[181],"significant":[182,252],"Nausea,":[191],"headache,":[192],"dry":[193],"mouth,":[194],"constipation,":[195],"diarrhea,":[196],"vomiting,":[197],"dizziness,":[198],"flatulence":[200],"reported":[202],"5%":[205],"receiving":[208],"vortioxetine.":[209],"Discontinuation":[210],"due":[211],"adverse":[213],"occurred":[215],"7":[217],"(4.4%)":[219],"group,":[223,231],"(5.2%)":[225],"12":[233],"(7.9%)":[234],"group.":[240],"ASEX":[241],"scores":[243],"similar":[245],"across":[246],"groups.":[247],"There":[248],"no":[250],"clinically":[251],"trends":[253],"within":[254],"between":[256],"treatment":[257,288],"groups":[258],"on":[259,280],"C-SSRS,":[261],"laboratory":[262],"values,":[263],"electrocardiogram,":[264],"vital":[266],"sign":[267],"parameters.":[268],"CONCLUSIONS:":[269],"In":[270],"this":[271],"did":[274],"differ":[276],"significantly":[277],"after":[284],"weeks":[286],"subjects.":[291],"TRIAL":[292],"REGISTRATION:":[293],"ClinicalTrials.gov":[294],"identifier:":[295],"NCT01179516.":[296]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}